Target Discovery

Executive Summary

Target Discovery is a US-based proteomics and biomarker discovery services company founded in 2002. It leverages mass spectrometry, bioinformatics, and advanced analytical technologies to provide affordable, accurate, and simplified testing solutions across clinical, forensic, food, beverage, agricultural, and environmental sectors. By making complex bio/chemical analysis accessible with push-button simplicity and clear reporting, the company addresses a broad market need for reliable diagnostic and analytical services. Despite its long operating history, Target Discovery remains privately held with no disclosed funding rounds or valuation. Its service-oriented model positions it as a niche player in the diagnostics space, though competitive pressures and limited public visibility constrain growth potential. The company's ability to cross-sell into multiple industries provides some revenue diversification, but lack of recent catalysts or expansion news suggests a steady-state operation with modest upside.